secwatch / observer
8-K filed May 21, 2026, 4:01 PM ET ticker JSPR CIK 0001788028
leadership confidence high sentiment neutral materiality 0.25

Jasper Therapeutics director Christian Nolet resigns; Svetlana Lucas joins audit committee

Jasper Therapeutics, Inc.

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001213900-26-060029
form_type
8-K
ticker
JSPR
cik
0001788028
company_name
Jasper Therapeutics, Inc.
filed_at
2026-05-21T20:01:33+00:00
discovered_at
2026-05-21T20:02:00.437571+00:00
generated_at
2026-05-21T20:02:30.971323+00:00
sec_items
["5.02", "9.01"]
event_type
leadership
sentiment
neutral
materiality_score
0.25
calibrated_materiality_score
0.25
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001213900-26-060029
json_url
https://secwatch.observer/filing/0001213900-26-060029.json
markdown_url
https://secwatch.observer/filing/0001213900-26-060029.md
text_url
https://secwatch.observer/filing/0001213900-26-060029.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1788028/000121390026060029/0001213900-26-060029-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1788028/000121390026060029/ea0291168-8k_jasper.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Christian Nolet

Director
JSPR · Jasper Therapeutics, Inc.
Effective
2026-05-15
Filed
May 21, 2026, 4:01 PM ET
On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.

Source-grounded claims

ea19a77ff0

Christian Nolet resigned as Director at Jasper Therapeutics, Inc..

On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

Comparable filings

FUNC

First United appoints Jason B. Rush as Chairman of the Board, effective May 27, 2026

FIRST UNITED CORP/MD/ May 28, 2026, 4:13 PM ET leadership Items 5.02, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.

Comparable filing

Mr. Rush was elected to the Board by the Corporation’s shareholders at the 2026 annual meeting of shareholders held on May 7, 2026.

Filing page SEC filing

FBIZ

Scott M. Ferris appointed to FBIZ Board, effective June 1, 2026

FIRST BUSINESS FINANCIAL SERVICES, INC. May 28, 2026, 4:02 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.

Comparable filing

appointed Mr. Scott M. Ferris as a Class III Director to fill the vacancy created by this increase.

Filing page SEC filing

FRST

Primis Financial elects two new board members; Clagett and Kabbash depart

Primis Financial Corp. May 27, 2026, 5:19 PM ET leadership Items 5.02, 5.07, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.

Comparable filing

directors Robert Y. Clagett and Charles A. Kabbash did not stand for re-election at the annual meeting of stockholders held on May 21, 2026

Filing page SEC filing

INTEGRAL TECHNOLOGIES INC

Integral Technologies appoints Michael Pruitt to Board of Directors

INTEGRAL TECHNOLOGIES INC May 27, 2026, 4:37 PM ET leadership Items 5.02, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.

Comparable filing

On May 20, 2026, the Board of Directors (the “Board”) of Integral Technologies Inc. (the “Company”) appointed Michael Pruitt to serve as a member of the Board.

Filing page SEC filing

MCHP

Microchip appoints former SVP Mitch Little to board, effective June 1, 2026

MICROCHIP TECHNOLOGY INC June 1, 2026, 4:18 PM ET leadership Items 5.02

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.

Comparable filing

appointed Mitch Little, former Senior Vice President, Worldwide Client Engagement of Microchip, as a member of the Board, effective June 1, 2026.

Filing page SEC filing

PUMP

Director Alex Volkov resigns from ProPetro board after Pioneer (Exxon) sells all shares

ProPetro Holding Corp. June 1, 2026, 4:16 PM ET leadership Items 5.02

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.

Comparable filing

On May 28, 2026, ProPetro Holding Corp. (the “Company”) announced the resignation of Alex V. Volkov from the Company’s Board of Directors (the “Board”).

Filing page SEC filing

DE

Deere director Dmitri Stockton will not seek re-election at 2027 annual meeting

DEERE & CO June 1, 2026, 4:15 PM ET leadership Items 5.02

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.

Comparable filing

On May 26, 2026, Dmitri Stockton notified the Board of Directors (the “Board”) of Deere & Company (the “Company”) that he would not stand for re-election as a director at the 2027 annual meeting of stockholders.

Filing page SEC filing

DY

Dycom board reduced to nine; two directors retire after annual meeting

DYCOM INDUSTRIES INC June 1, 2026, 8:04 AM ET leadership Items 5.02, 5.07

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.

Comparable filing

Ms. Laurie J. Thomsen did not stand for election at the 2026 Annual Meeting of Shareholders held on May 28, 2026 (the “2026 Annual Meeting”) and retired from the Board effective at the conclusion of the 2026 Annual Meeting.

Filing page SEC filing

Source: SEC EDGAR
accession 0001213900-26-060029

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.